Table 1: Characteristics of All Patients With Metastatic Humerus Per Study (%).
|
Author, year |
Implant |
Patients |
humerus |
Pathological fractures |
Median age
|
Minimum follow-upm |
One year survival in (%) |
|
Lewallen RP et al (1982) |
IMN |
55 |
55 |
-- |
-- |
-- |
10Ma |
|
Capanna R et al (1988) |
EPR |
20 |
19 |
-- |
-- |
-- |
-- |
|
Yazawa Y et al (1990) |
IMN |
166 |
41 |
30 |
62 |
24 |
40% |
|
Fuhrmann RA et al (2000) |
EPR |
22 |
22 |
-- |
57 |
47a |
-- |
|
Gebhart, M. et al (2001) |
EPR+IMN |
56 |
55 |
31 |
62 |
1 |
9a |
|
Bickels J et al (2002) |
EPR |
134 |
12 |
-- |
-- |
24 |
-- |
|
Bauze AJ, et al (2003) |
IMN |
31 |
31 |
25 |
67 |
-- |
-- |
|
Bauze AJ et al (2006) |
EPR+IMN |
96 |
77 |
-- |
63 |
8a |
43.5% |
|
Thai DM et al (2008) |
EPR |
154 |
37 |
-- |
59 |
-- |
69.5% |
|
Scotti, C. et al (2008) |
EPR |
40 |
40 |
12 |
67 |
-- |
70% |
|
Cannon CP et al (2009) |
EPR |
83 |
67 |
|
55 |
24 |
55.8% |
|
Piccioli A et al (2010) |
EPR+IMN |
85 |
87 |
76 |
59 |
8.3a |
67.3% |
|
Siegel, H.J. et al (2010) |
ORIF |
32 |
23 |
-- |
52 |
17.6a |
-- |
|
Raiss, P. et al (2010) |
EPR |
43 |
30 |
-- |
60 |
38a |
77%（2） |
|
Griffiths, D. et al (2011) |
EPR |
68 |
30 |
-- |
53 |
71a |
-- |
|
Wedin R et al (2012) |
EPR+IMN+ ORIF |
214 |
204 |
173 |
67 |
8a |
40% |
|
Henrichs MP et al (2014) |
EPR |
82 |
26 |
-- |
63 |
-- |
94.7% |
|
Pruksakorn D et al (2015) |
EPR+ ORIF |
27 |
27 |
-- |
-- |
16a |
91.7% |
|
Janssen SJ et al (2016) |
EPR+IMN+ ORIF |
295 |
292 |
237 |
63 |
4a |
49% |
|
Choi ES et al (2016) |
IMN |
32 |
32 |
21 |
-- |
14.2a |
48% |
|
Schmolders J et al (2016) |
EPR |
30 |
21 |
-- |
-- |
26a |
83% |
--, not available; EPR, endoprosthesis; IMN, intramedullary nail; ORIF, open reduction internal fixation.
a Mean age.
m In months.